Funding Rounds
Rivermark Medical October 2024 Series C Funding Round
Rivermark Medical, Inc.Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
Summary
Stage: Series C
Raised Amount: $30.00M
Raised Date: 2024-10-10
